Sanprobi Sp. z o.o.   Report issue

For profit
Founded: Szczecin Poland (1991)
Status: No NME R&D (1991)

Organization Overview

First Clinical Trial
2018
NCT04089280
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Sanprobi Sp. z o.o., Sp. k., Szczecin, Poland

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 6